跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,433 条关于
“RSK”
全部
18,433
临床试验
16,197
药物
833
机构
19
资讯
1,384
去年
RSK1 Inhibitor PMD-026 Shows Promise in Treating Blood Cancers in Addition to Breast Cancer
去年
Phoenix Molecular Designs Initiates Phase 2 Trial of PMD-026 Combination Therapy for Advanced Breast Cancer
去年
Aptose and NCI Partner to Advance Tuspetinib in AML and MDS Trials
去年
Aptose Biosciences' Tuspetinib Shows Promise in AML Triplet Therapy, Receives $10M Loan from Hanmi
去年
FDA Approves Abrysvo for RSV Prevention in Adults Aged 18-59 at Increased Risk
去年
RSV Vaccine Sales Decline for GSK and Pfizer in the US
去年
FDA Approves Abrysvo, First RSV Vaccine for Younger At-Risk Adults
去年
GSK's Arexvy Shows Sustained RSV Protection Over Three Seasons; Co-administration with Shingrix Yields Positive Results
去年
RSV Vaccines Face Uptake Challenges Despite FDA Approval for Older Adults
去年
Limited Treatment Options Highlight Critical Role of RSV Prevention in High-Risk Adults
第 1 页,共 139 页
上一页
下一页